Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling
Tóm tắt
Alterations in transcription, RNA editing, translation, protein processing, and clearance are a consistent feature of Alzheimer's disease (AD) brain. To extend our initial study (Alzheimer Reports [2000] 3:161‐167), RNA samples isolated from control and AD hippocampal cornu ammonis 1 (CA1) were analyzed for 12633 gene and expressed sequence tag (EST) expression levels using DNA microarrays (HG‐U95Av2 Genechips; Affymetrix, Santa Clara, CA). Hippocampal CA1 tissues were carefully selected from several hundred potential specimens obtained from domestic and international brain banks. To minimize the effects of individual differences in gene expression, RNA of high spectral quality (A260/280 ≥ 1.9) was pooled from CA1 of six control or six AD subjects. Results were compared as a group; individual gene expression patterns for the most‐changed RNA message levels were also profiled. There were no significant differences in age, postmortem interval (mean ≤ 2.1 hr) nor tissue pH (range 6.6–6.9) between the two brain groups. AD tissues were derived from subjects clinically classified as CDR 2‐3 (CERAD/NIA). Expression data were analyzed using GeneSpring (Silicon Genetics, Redwood City, CA) and Microarray Data Mining Tool (Affymetrix) software. Compared to controls and 354 background/alignment markers, AD brain showed a generalized depression in brain gene transcription, including decreases in RNA encoding transcription factors (TFs), neurotrophic factors, signaling elements involved in synaptic plasticity such as synaptophysin, metallothionein III, and metal regulatory factor‐1. Three‐ or morefold increases in RNAs encoding DAXX, cPLA2, CDP5, NF‐κBp52/p100, FAS, βAPP, DPP1, NFIL6, IL precursor, B94, HB15, COX‐2, and CEX‐1 signals were strikingly apparent. These data support the hypothesis of widespread transcriptional alterations, misregulation of RNAs involved in metal ion homeostasis, TF signaling deficits, decreases in neurotrophic support and activated apoptotic and neuroinflammatory signaling in moderately affected AD hippocampal CA1. © 2002 Wiley‐Liss, Inc.
Từ khóa
Tài liệu tham khảo
Franceschi C, 2001, Neuroinflammation and the genetics of Alzheimer's disease: the search for a pro‐inflammatory phenotype, Aging, 13, 163
Hromas R, 1997, Cloning and characterization of exodus, a novel beta‐chemokine, Blood, 89, 3315
Lukiw WJ, 1996, Synaptic and cytoskeletal RNA message levels in sporadic Alzheimer neocortex, Alzheimer's Res, 2, 221
Lukiw WJ, 2000, Analysis of 1184 gene transcript levels in AD CA1 hippocampus: synaptic signaling and transcription factor deficits and upregulation of pro‐inflammatory pathways, Alzheimer's Rep, 3, 161
Lukiw WJ, 2000, Potential of transcriptional coordination of nine genes associated with Alzheimer's disease, Alzheimer's Rep, 4, 233
Martin LJ, 2001, Neuronal cell death in nervous system development, disease, and injury, Int J Mol Med, 7, 455
McGeer EG, 1999, Brain inflammation in Alzheimer disease and the therapeutic implications, Curr Pharm Res, 10, 821, 10.2174/1381612805666230111212056
McGeer PL, 2001, Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Interleukin‐1 and the immunogenetics of Alzheimer disease, J Neuropathol Exp Neurol, 59, 471
Rogers J., 1995, Inflammation as a pathogenic mechanism in Alzheimer's disease, Arzneimittelforschung, 45, 439
Ross J, 1996, Control of messenger RNA stability in higher eukaryotes, Trends Genet, 5, 171, 10.1016/0168-9525(96)10016-0
Sarma V, 1992, Cloning of a novel tumor necrosis factor‐alpha‐inducible primary response gene that is differentially expressed in development and capillary tube‐like formation in vitro, J Immunol, 148, 3302, 10.4049/jimmunol.148.10.3302
Sutcliffe JG, 2001, Open‐system approaches to gene expression in the CNS, J Neurosci, 21, 8306, 10.1523/JNEUROSCI.21-21-08306.2001
Tol J, 1999, Genetic and environmental factors in Alzheimer's disease, Rev Neurol, 155, 10